Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06883084
What this trial is testing

Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerLymph Node Metastasis
Yanhong Deng 1,080
Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)WithdrawnNCT00244348
What this trial is testing

Hepatic Artery Infusion With Oxaliplatin

Who this might be right for
Colorectal CancerMetastasisLiver Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT00116506
What this trial is testing

Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT01532804
What this trial is testing

2nd-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 83
Testing effectiveness (Phase 2)Study completedNCT01975077
What this trial is testing

A Phase Ib Study of Fruquintinib in 3rd Line mCRC

Who this might be right for
Colorectal Cancer
Hutchison Medipharma Limited 62
Large-scale testing (Phase 3)Study completedNCT00003287
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 554
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Large-scale testing (Phase 3)Study completedNCT05198934
What this trial is testing

Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

Who this might be right for
Colorectal Cancer (CRC)
Amgen 160
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Large-scale testing (Phase 3)Study completedNCT00252564
What this trial is testing

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
US Oncology Research 247
Testing effectiveness (Phase 2)UnknownNCT00043199
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Testing effectiveness (Phase 2)Study completedNCT00475293
What this trial is testing

Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 85
Testing effectiveness (Phase 2)Study completedNCT02613221
What this trial is testing

A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 56
Testing effectiveness (Phase 2)WithdrawnNCT03340558
What this trial is testing

Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Niharika Mettu
Testing effectiveness (Phase 2)Looking for participantsNCT07292298
What this trial is testing

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

Who this might be right for
Rectal AdenocarcinomaRectal Cancer
University of Colorado, Denver 44
Testing effectiveness (Phase 2)Study completedNCT01640444
What this trial is testing

Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)

Who this might be right for
Colorectal Cancer Metastatic
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 240
Testing effectiveness (Phase 2)Ended earlyNCT05572684
What this trial is testing

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsMicrosatellite Instability LowMicrosatellite Instability High+9 more
NextCure, Inc. 97
Next Page